News
02-17-2021, 11:55 PM
A Ludwig Cancer Research study has identified a novel mechanism by which a type of cancer immunotherapy known as CTLA-4 blockade can disable suppressive immune cells to aid the destruction of certain tumors.
More... (https://www.news-medical.net/news/20210218/Cancer-immunotherapy-can-disable-suppressive-immune-cells-to-aid-tumor-destruction.aspx)
More... (https://www.news-medical.net/news/20210218/Cancer-immunotherapy-can-disable-suppressive-immune-cells-to-aid-tumor-destruction.aspx)